
Lorlatinib is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has spread to other parts of our body.
In today's episode we have discussed how it works, who are the eligible for the same and the common side effects of the drug.
We hope this helps.
See you soon.
Jai Hind